- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06440343
Effects of Acute Carbohydrate Intake Intra-training in Crosstraining
Effects of Acute Carbohydrate Intake Intra-training in Crosstraining Athletes: a Randomized, Placebo-controlled Crossover Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Carbohydrate intake during exercise could decrease the subjective perceived exertion and promote recovery during high-intensity and intermittent exercises such as crosstraining. Nevertheless, despite extensive research on carbohydrate ingestion during exercise across different sports disciplines, its effects have not been investigated in crosstraining sessions.
23 male trained crosstraining athletes will ingest carbohydrates (60g of maltodextrin + fructose, 2:1 ratio) or placebo during a one-and-a-half-hour crosstraining session. The session will consist of a warm-up, a weightlifting part, a strength part, a WOD, and an AMRAP. The rating of perceived exertion (RPE) will be assessed using the validated Borg scale at the beginning of the session, after each part of the training, and at the end of the session. DOMS will be assessed using a visual analog scale at 24 and 48 hours after the crosstraining session.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Granada, Spain
- University of Granada
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: 18-35 years.
- Body mass index: 18.5-30 kg/m2.
- Ability to understand the instructions, objectives, and study protocol.
- Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
- Resident on the island of Tenerife.
Exclusion Criteria:
- History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
- Any chronic condition in which the intake of nutritional supplements is not advisable.
- Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
- Use of medications that may affect the study results.
- Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in - weight).
- Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
- On a special diet or prescribed for other reasons (e.g., celiac disease).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Carbohydrates
60g of maltodextrin + fructose, 2:1 ratio
|
60g of maltodextrin + fructose, 2:1 ratio
|
|
Placebo Comparator: Placebo
Preparation of colorants, sweeteners, aromas and acidulants
|
Placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise-induced muscle damage and recovery measured through the countermovement jump
Time Frame: 1 hour 30 minutes
|
Countermovement jump height
|
1 hour 30 minutes
|
|
Exercise-induced muscle damage and recovery through the DOMS scale
Time Frame: 1 hour 30 minutes
|
Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)
|
1 hour 30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feeling sensations
Time Frame: 1 hour 30 minutes
|
Feeling scale
|
1 hour 30 minutes
|
|
Capillar lactate levels
Time Frame: 1 hour 30 minutes
|
Capillar lactate levels
|
1 hour 30 minutes
|
|
Capilar glucose levels
Time Frame: 1 hour 30 minutes
|
Capilar glucose levels
|
1 hour 30 minutes
|
|
Subjective fatigue throughe the RPE scale
Time Frame: 1 hour 30 minutes
|
Rate of perceived exertion scale
|
1 hour 30 minutes
|
|
Performance: Weight used in the crosstraining session
Time Frame: 1 hour 30 minutes
|
Weight used in the crosstraining session
|
1 hour 30 minutes
|
|
Performance: Repetitions performed in the crosstraining session
Time Frame: 1 hour 30 minutes
|
Repetitions performed in the crosstraining session
|
1 hour 30 minutes
|
|
Performance: Rounds performed in the crosstraining session
Time Frame: 1 hour 30 minutes
|
Rounds performed in the crosstraining session
|
1 hour 30 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CROSSCARB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.